William Blair & Company
ABBV icon

William Blair & Company’s AbbVie ABBV Stock Holding History

William Blair & Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,100
Closed -$80K – 1357
2017
Q2 		$80K Buy
1,100
+200
+22% +$13.4K ﹤0.01% 1438
2017
Q1 		$59K Buy
900
+200
+29% +$12.6K ﹤0.01% 1324
2016
Q4 		$44K Buy
+700
New +$42.7K ﹤0.01% 1264

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair & Company's ABBV Position: Q1 2026 in Review

William Blair & Company reduced its AbbVie (ABBV) stake by 0.25% in Q1 2026, selling an estimated $744K and leaving 1,334,109 shares worth $290M. The position accounts for 0.83% of the portfolio, ranked #23.

William Blair & Company first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $306M in Q4 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • William Blair & Company held 1,334,109 shares of AbbVie worth $290M as of Q1 2026.
  • William Blair & Company sold 3,352 AbbVie shares in Q1 2026, an estimated $744K.
  • AbbVie made up 0.83% of William Blair & Company's portfolio in Q1 2026, its #23 holding.
  • William Blair & Company first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • William Blair & Company's AbbVie position peaked at $306M in Q4 2025.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.